Topvision Eye Specialist BhdXKLS:0332 52 Return-on-Tangible-Equity is 0.77% as of Mar. 2026, which is 93% below its 10-year median of 11.62. GuruFocus rates XKLS:0332 with a GF Score™ of 52/100 and a GF Value™ of RM0.69 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 579 Healthcare Providers & Services companies, Topvision Eye Specialist Bhd ranks worse than 68.05% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Topvision Eye Specialist Bhd's annualized net income for the quarter that ended in Mar. 2026 was RM0.33 Mil. Topvision Eye Specialist Bhd's average shareholder tangible equity for the quarter that ended in Mar. 2026 was RM42.80 Mil. Therefore, Topvision Eye Specialist Bhd's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 0.77%.
The historical rank and industry rank for Topvision Eye Specialist Bhd's Return-on-Tangible-Equity or its related term are showing as below:
XKLS:0332'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 2.7 Med: 11.62 Max: 25.67
Current: 2.77
During the past 11 years, Topvision Eye Specialist Bhd's highest Return-on-Tangible-Equity was 25.67%. The lowest was 2.70%. And the median was 11.62%.
XKLS:0332's Return-on-Tangible-Equity is ranked worse than 68.05% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.21
vs XKLS:0332: 2.77
Topvision Eye Specialist Bhd (XKLS:0332) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Topvision Eye Specialist Bhd Return-on-Tangible-Equity Related Terms
Topvision Eye Specialist Bhd Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Topvision Eye Specialist Bhd Return-on-Tangible-Equity Chart
XKLS:0332 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Topvision Eye Specialist Bhd's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Topvision Eye Specialist Bhd Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Topvision Eye Specialist Bhd's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Topvision Eye Specialist Bhd's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.77% mean?
Topvision Eye Specialist Bhd (XKLS:0332) has a Return-on-Tangible-Equity of 0.77% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Topvision Eye Specialist Bhd and its competitors. This is 93% below median its historical median of 11.62. Over the past decade, Topvision Eye Specialist Bhd's Return-on-Tangible-Equity has ranged from 2.70 to 25.67. According to the industry distribution chart, Topvision Eye Specialist Bhd ranks #394 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 68%.
Is Topvision Eye Specialist Bhd's Return-on-Tangible-Equity too high?
Topvision Eye Specialist Bhd's current Return-on-Tangible-Equity of 0.77% is 93% below median its 10-year median of 11.62. Over the past 10 years, this metric has ranged from a low of 2.70 to a high of 25.67. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.21. Topvision Eye Specialist Bhd's value of 0.77% is 92.5% below this industry median. Based on the distribution chart, Topvision Eye Specialist Bhd ranks #394 out of 579 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Topvision Eye Specialist Bhd has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Topvision Eye Specialist Bhd's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Topvision Eye Specialist Bhd ranks #394 out of 579 companies for Return-on-Tangible-Equity. This places Topvision Eye Specialist Bhd in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.21. Topvision Eye Specialist Bhd's value of 0.77% is 92.5% below this benchmark. Historically, Topvision Eye Specialist Bhd's own Return-on-Tangible-Equity has ranged from 2.70 to 25.67 over the past decade. While the company's 10-year median is 11.62 vs. the industry median of 10.21, Topvision Eye Specialist Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.21, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Topvision Eye Specialist Bhd's current Return-on-Tangible-Equity of 0.77% is 92.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Topvision Eye Specialist Bhd and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Topvision Eye Specialist Bhd's current Return-on-Tangible-Equity is 0.77%, which is 93% below median its own 10-year median of 11.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Topvision Eye Specialist Bhd stock overvalued right now?
Based on GuruFocus' analysis, Topvision Eye Specialist Bhd (XKLS:0332) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.69, compared to a current price of RM0.17 — trading 75.4% below its estimated fair value. The current Return-on-Tangible-Equity is 0.77%, which is 93% below median its 10-year median of 11.62 and 92.5% below the Healthcare Providers & Services industry median of 10.21. Topvision Eye Specialist Bhd's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Topvision Eye Specialist Bhd (XKLS:0332), the current Return-on-Tangible-Equity is 0.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Topvision Eye Specialist Bhd (XKLS:0332) Overvalued in 2026?
Based on GuruFocus' analysis, Topvision Eye Specialist Bhd stock appears to be undervalued.
The current stock price of RM0.17 is trading 75.4% below its estimated GF Value™ of RM0.69.
GuruFocus considers Topvision Eye Specialist Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0332:
Return-on-Tangible-Equity: 0.77% (93% below median its 10-year median of 11.62)
GF Value™: RM0.69 vs. price of RM0.17 (75.4% below fair value)
Industry Position: 92.5% below the Healthcare Providers & Services median (#394 of 579)
No single metric tells the full story. See the XKLS:0332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Topvision Eye Specialist Bhd is principally involved in the provision of ophthalmology services and related medical consultancy services. The company is also engaged in the marketing of eye supplements and health food products. The company derives a majority of its revenue from its ophthalmology services business, providing treatments for general as well as complex eye diseases. Geographically, it operates in Malaysia.
52GF Score
Get the complete analysis for XKLS:0332
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0332 has been successfully added to your 
